Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05993195 · ClinicalTrials.gov registry record
Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion
A clinical trial of Degenerative Spondylolisthesis and Lumbar Spondylosis, sponsored by Lahey Clinic.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05993195: Completed study of Degenerative Spondylolisthesis and Lumbar Spondylosis, sponsored by Lahey Clinic.
NCT05993195 is a study of Degenerative Spondylolisthesis and Lumbar Spondylosis that has completed, run by Lahey Clinic. The registered enrollment target is 100 participants, below the 262-participant average among 5 other Degenerative Spondylolisthesis trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05993195, a study of Degenerative Spondylolisthesis and Lumbar Spondylosis, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this early study is to compare the clinical results of the new Conduit Interbody device to the traditional Concorde Bullet Device. The primary objective is to explore the rates and reasons for re-operation between both constructs at 2 years.
Primary Outcome
a comparison of Concorde Bullet Device versus Conduit Titanium Interbody Graft for lumbar fusion in terms of reoperation rate
Conditions Studied
Interventions
- DEVICE Conduit Titanium Interbody Graft
- DEVICE Concorde Bullet Device
Study Locations (1)
Massachusetts
- Lahey Hospital and Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2024-03-31 |
What the finished NCT05993195 record still lists
NCT05993195 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 262-participant average among 5 other Degenerative Spondylolisthesis trials with a reported enrollment target (62% lower).
The record links to 3 conditions, with Degenerative Spondylolisthesis appearing as the primary indexed condition, and to 2 interventions - of which Conduit Titanium Interbody Graft is the first listed.
NCT05993195 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05993195 about?
NCT05993195 is a clinical study titled "Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion". The purpose of this early study is to compare the clinical results of the new Conduit Interbody device to the traditional Concorde Bullet Device. The primary objective is to explore the rates and reasons for re-operation between both constructs at 2 years.
What is the current status of trial NCT05993195?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-03-12. Estimated completion is 2024-03-31.
What conditions does trial NCT05993195 study?
This clinical trial studies the following conditions: Degenerative Spondylolisthesis, Lumbar Spondylosis, Lumbar Spondylolisthesis.
What interventions are being tested in trial NCT05993195?
The interventions under investigation include: Conduit Titanium Interbody Graft (DEVICE), Concorde Bullet Device (DEVICE).
Who is sponsoring clinical trial NCT05993195?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05993195 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Spondylolisthesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery
RECRUITING · Phase 4
-
SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion
ACTIVE NOT RECRUITING · NA
-
LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis
ACTIVE NOT RECRUITING · NA
-
Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion
COMPLETED · Phase 2
-
Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI